Updates to the 2021 Adult Immunization Schedule
The ACIP emphasizes the importance of routine vaccinations during the pandemic to prevent diseases.
Guidelines
USPSTF Advises Screening for Gestational Diabetes Mellitus
GDM screening recommended at or after, but not before, 24 weeks of gestation in asymptomatic pregnant individuals
New Guidelines for the Management of Lyme Disease
The Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology provided new clinical practice guidelines for Lyme disease prevention, diagnosis, and treatment.
ACIP Provides Recommendations on Meningococcal Vaccination
Vaccination with MenACWY recommended for adolescents aged 11 to 12 years with booster at 16 years.
ATS: Clinical Practice Guidelines on the Pharmacologic Management of COPD
The American Thoracic Society has released a new clinical practice guideline on the pharmacologic management of chronic obstructive pulmonary disease.
NAMS 2020 Genitourinary Syndrome of Menopause Position Statement Released
The North American Menopause Society (NAMS) recently announced the publication of its 2020 Genitourinary Syndrome of Menopause (GSM) position statement that included updated recommendations on the most current safe and effective therapeutic options for women with GSM. Despite having a variety of over-the-counter and prescription treatment options, GSM remains underdiagnosed and undertreated. Since the NAMS…
ADA Updates Guideline for Pharmacotherapy of T2DM
Metformin preferred as initial agent; early combined therapy can extend time to treatment failure
American Cancer Society Updates HPV Vaccination Guidelines
Vaccination should be routinely offered at age 9 to 12 years; catch-up vaccination recommended through age 26.
Updated 2020 American College of Rheumatology Gout Management Guidelines
The American College of Rheumatology developed guidelines for the management of gout, including use of urate-lowering therapy, flare treatment, and lifestyle and medication recommendations.
New Guideline Issued for Managing Advanced Prostate Cancer
Three major medical organizations have issued recommendations for the diagnosis and treatment of advanced prostate cancer, including metastatic hormone-sensitive disease and nonmetastatic and metastatic castration-resistant disease.
